LTR Pharma (ASX:LTP) OCF Margin %: -6,643.24% (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.56
! 1 Warning Sign
View Full Analysis

What is LTR Pharma OCF Margin %?

LTR Pharma ASX:LTP -4.27% 15 OCF Margin % is -6,643.24% as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, LTR Pharma ranks worse than 89.68% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. LTR Pharma's Cash Flow from Operations for the six months ended in Dec. 2025 was A$-4.92 Mil. LTR Pharma's Revenue for the six months ended in Dec. 2025 was A$0.07 Mil. Therefore, LTR Pharma's OCF Margin % for the quarter that ended in Dec. 2025 was -6,643.24%.

As of today, LTR Pharma's current OCF Yield % is -6.49%.

The historical rank and industry rank for LTR Pharma's OCF Margin % or its related term are showing as below:

ASX:LTP' s OCF Margin % Range Over the Past 10 Years
Min: -3038.36   Med: -3038.36   Max: -3038.36
Current: -4432.48

During the past 5 years, the highest OCF Margin % of LTR Pharma was -3038.36%. The lowest was -3038.36%. And the median was -3038.36%.

ASX:LTP's OCF Margin % is ranked worse than
89.68% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs ASX:LTP: -4432.48

LTR Pharma OCF Margin % Related Terms

LTR Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for LTR Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma OCF Margin % Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
0.00 0.00 0.00 0.00 -3,038.36

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 -3,798.41 -2,461.45 -6,643.24

ASX:LTP vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, LTR Pharma's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's OCF Margin % distribution charts can be found below:

* The bar in red indicates where LTR Pharma's OCF Margin % falls into.


ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

LTR Pharma's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-4.436/0.146
=-3,038.36 %

LTR Pharma's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-4.916/0.074
=-6,643.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -6,643.24% mean?
LTR Pharma (ASX:LTP) has a OCF Margin % of -6,643.24% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LTR Pharma and its competitors. According to the industry distribution chart, LTR Pharma ranks #860 out of 959 companies in the Biotechnology industry, placing it in the top 89.7%.
Is LTR Pharma's OCF Margin % too high?
LTR Pharma's current OCF Margin % is -6,643.24%. Based on the distribution chart, LTR Pharma ranks #860 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LTR Pharma ranks #860 out of 959 companies for OCF Margin %. This places LTR Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LTR Pharma and its competitors. LTR Pharma's current OCF Margin % is -6,643.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current OCF Margin % of -6,643.24%. The current OCF Margin % is -6,643.24%. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current OCF Margin % is -6,643.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.56
Price